Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

Matthew D. Hellmann; Boris Reva; Helena Yu; Valerie W. Rusch; Naiyer A. Rizvi; Mark G. Kris; Maria E. Arcila

doi:10.1097/JTO.0000000000000221

Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

Matthew D. Hellmann, Boris Reva, Helena Yu, Valerie W. Rusch, Naiyer A. Rizvi, Mark G. Kris, Maria E. Arcila

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Original language	English
Pages (from-to)	e73-e74
Journal	Journal of Thoracic Oncology
Volume	9
Issue number	10
DOIs	https://doi.org/10.1097/JTO.0000000000000221
State	Published - 1 Oct 2014
Externally published	Yes

Access to Document

10.1097/JTO.0000000000000221

Cite this

@article{fb7ac634ca864c758e36b6ce128a121a,

title = "Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib",

author = "Hellmann, {Matthew D.} and Boris Reva and Helena Yu and Rusch, {Valerie W.} and Rizvi, {Naiyer A.} and Kris, {Mark G.} and Arcila, {Maria E.}",

year = "2014",

month = oct,

day = "1",

doi = "10.1097/JTO.0000000000000221",

language = "English",

volume = "9",

pages = "e73--e74",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

AU - Hellmann, Matthew D.

AU - Reva, Boris

AU - Yu, Helena

AU - Rusch, Valerie W.

AU - Rizvi, Naiyer A.

AU - Kris, Mark G.

AU - Arcila, Maria E.

PY - 2014/10/1

Y1 - 2014/10/1

UR - http://www.scopus.com/inward/record.url?scp=84925813420&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000221

DO - 10.1097/JTO.0000000000000221

M3 - Article

C2 - 25521405

AN - SCOPUS:84925813420

SN - 1556-0864

VL - 9

SP - e73-e74

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -